Seeing Is Believing
Currently out of the existing stock ratings of Jim Birchenough, 84 are a BUY (67.2%), 37 are a HOLD (29.6%), 4 are a SELL (3.2%).
Analyst Jim Birchenough works at WELLS FARGO with a stock forecast success ratio of 61.1% fulfilled within 256.14 days on average.
Jim Birchenough’s has documented 321 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RGLS, Regulus Therapeutics at 13-Mar-2024.
Analyst best performing recommendations are on INFI (INFINITY PHARMACEUTICALS).
The best stock recommendation documented was for BLCM (BELLICUM PHARMACEUTICALS) at 2/14/2020. The price target of $4 was fulfilled within 31 days with a profit of $6.42 (61.61%) receiving and performance score of 19.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
30
3 years 6 months 28 days ago
2/8 (25%)
$14.76 (96.85%)
30
Hold
20
$1.83 (10.07%)
31
3 years 10 months 23 days ago
2/4 (50%)
$0.93 (13.82%)
13
Hold
24
$5.83 (32.09%)
33
4 years 6 months 6 days ago
4/5 (80%)
$5.96 (33.04%)
39
Hold
5 years 6 months 4 days ago
2/2 (100%)
$1.2 (5.04%)
27
Which stock is Jim Birchenough is most bullish on?
Which stock is Jim Birchenough is most reserved on?
What Year was the first public recommendation made by Jim Birchenough?